title: Wavelength and conduction inhomogeneity in each atrium in patients with isolated mitral valve disease and atrial fibrillation.
abstract: BACKGROUND
  Patients with mitral valve disease frequently have atrial fibrillation (AF), and the left atrium is presumed to be the primary atrium that develops AF. However, it is still not clear whether the electrophysiologic abnormalities responsible for AF are confined to the left atrium in this subset of patients.
  
  
  RESULTS
  To examine the AF vulnerability of each atrium, we measured the wavelength and inhomogeneity of the conduction at the lateral right atrium, lateral left atrium, and Bachmann's bundle after defibrillation of AF in seven patients undergoing the maze procedure and mitral valve surgery for AF and isolated mitral valve disease, respectively (AF group). The data were compared with five coronary surgery patients in sinus rhythm (SR group). The wavelength in the AF group was significantly shorter (P < 0.05) than in the SR group not only at the lateral left atrium (225 +/- 62 vs 285 +/- 36 mm) but also at the lateral right atrium (214 +/- 54 vs 254 +/- 34 mm). The variation coefficient of the local maximum activation phase difference in the AF group (1.9 +/- 0.8 at the right atrium, 2.1 +/- 0.8 at the lateral left atrium, and 2.0 +/- 0.6 at Bachmann's bundle) was significantly greater (P < 0.05) than in the SR group at all atrial regions.
  
  
  CONCLUSIONS
  AF vulnerability was not confined to the left atrium immediately after defibrillation in AF patients with isolated mitral valve disease. Electrical remodeling resulting from perpetuation of AF, pathological changes extending to the right atrium, geometric changes caused by the atrial interactions occurring across the interatrial septum, or a combination of these may explain the results.
authors.affiliation: Department of Cardiothoracic Surgery, Nippon Medical School, Tokyo, Japan. Nitta_Takashi/surg2@nms.ac.jp
authors.forename: T
authors.initials: T
authors.lastname: Nitta
authors.forename: H
authors.initials: H
authors.lastname: Imura
authors.forename: R
authors.initials: R
authors.lastname: Bessho
authors.forename: H
authors.initials: H
authors.lastname: Hosaka
authors.forename: S
authors.initials: S
authors.lastname: Yamauchi
authors.forename: S
authors.initials: S
authors.lastname: Tanaka
mesh_terms: D001281:Atrial Fibrillation / Q000503:physiopathology* / Q000628:therapy; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000503:physiopathology / Q000601:surgery; D017548:Echocardiography, Transesophageal; D004554:Electric Countershock; D004594:Electrophysiology / Q000379:methods; D005260:Female; D005500:Follow-Up Studies; D006325:Heart Atria / Q000503:physiopathology*; D006329:Heart Conduction System / Q000503:physiopathology*; D006349:Heart Valve Diseases / Q000000981:diagnostic imaging / Q000503:physiopathology* / Q000601:surgery; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve; D016343:Monitoring, Intraoperative